EDINBURGH, Scotland, April 14, 2025 /PRNewswire/ — Chromatin Bioscience, a leader in the design of synthetic promoters and gene control systems, is pleased to announce a collaboration agreement with Astellas Pharma, a global life sciences company. Under the agreement, Chromatin…
